Clenergen Corporation (OTCBB : CRGE) Secures Exclusive License to Use
Proprietary Plant Adaption Tec
(Thomson Reuters ONE) - Clenergen Corporation CEO Mark Quinn today announced the acquisitionof an exclusive intellectual property license for use in India andSri Lanka from Star Biotechnology Ltd which will give his companyimmediate access to the technology and know-how required to increasethe rate of biomass production and so assist the generation of cleanelectricity through gasification."This is a significant source of plant science and expertise forClenergen and will literally accelerate the development of ourambitions in the field. We have been working with the science teamfor the past six months and I am glad to have now reached thismilestone",Said Mr. Quinn today.Using mother strains of Paulownia originating from Australia, thePolyploidy Technology Plant Adaption Process (PTPAP) will be appliedto produce an entirely new species of fast growing tree, specificallycultivated to thrive in the climate and soils of land leased byClenergen in India and Sri Lanka. It is projected that theapplication of PTPAP will result in up to a 40% increase in thegrowth of saplings within two years from planting.On granting the license to Clenergen, Star Biotechnology's StephenVon Peltz commented,"This is an exciting new license for an exciting, young company andwe are proud to supply the necessary knowledge and expertise requiredby Clenergen and their partners"As part of fifteen year license, Arbour Technologies Ltd ofQueensland, Australia has also been engaged to provide research,development and agronomy management for the cultivation of thisbiomass feedstock for gasification and the production of cleanelectricity by Clenergen.Speaking of their involvement, Arbour Technologies' Malcolm Lamontsaid,"We look forward to working on this innovative project and with allof the Clenergen team"Within six months of the exclusive license being effective, 18,000polyploidy Paulownia saplings and 6000 parent (non-polyploidy)saplings will be ready to plant and support clean electricityprojects. The Company's subsidiary, Clenergen India Private Limited,has executed a 71 MW Power Purchase Agreement with the Power TradingCorporation of India and is currently in the first phase ofdevelopment in the Tamilnadu region of India. This facility whenbuilt, will be able to utilize the biomass from the saplings toconvert into electricity.Notes for EditorsClenergen Corporation is a publicly listed company on the OTC stockmarket (symbol CRGE). Clenergen develops Clean Energy Generationprojects to address the requirement for renewable and sustainablesupplies of electricity. Clenergen installs and operates DistributedEnvironmental Power Systems (DEPS) and applies plant science to thecultivation of proprietary biomass feedstocks in order to providesustainable supplies of clean energy to regional, independent clientsand national grids.Notice Regarding Forward-Looking StatementsThis news release contains "forward-looking statements," as that termis defined in Section 27A of the United States Securities Act of 1933and Section 21E of the Securities Exchange Act of 1934. Statements inthis news release which are not purely historical are forward-lookingstatements and include any statements regarding beliefs, plans,expectations or intentions regarding the future, including but notlimited to our ability to accelerate the cultivation of proprietaryfeedstock and to establish our company as one of the leading biomasspower generating companies globally.Actual results could differ from those projected in anyforward-looking statements due to numerous factors. Such factorsinclude, among others, the inherent uncertainties associated withclean technologies; changes in the operating costs and changes ineconomic conditions and conditions in clean technologies. Theseforward-looking statements are made as of the date of this newsrelease, and we assume no obligation to update the forward-lookingstatements, or to update the reasons why actual results could differfrom those projected in the forward-looking statements. Although webelieve that the beliefs, plans, expectations and intentionscontained in this press release are reasonable, there can be noassurance those beliefs, plans, expectations or intentions will proveto be accurate. Investors should consult all of the information setforth herein and should also refer to the risk factors disclosureoutlined in our current and periodic reports filed from time-to-timewith the Securities and Exchange Commission.- END -This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 09.09.2009 - 14:07 Uhr
Sprache: Deutsch
News-ID 5634
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 291 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Clenergen Corporation (OTCBB : CRGE) Secures Exclusive License to Use
Proprietary Plant Adaption Tec"
steht unter der journalistisch-redaktionellen Verantwortung von
Clenergen Corporation Limited (UK) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
